Edesa Biotech
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$6,170,045 over the previous period. Total operating expenses were $7,014,744.

Profit Margin

Edesa Biotech, Inc. (NASDAQ:EDSA): Profit margin
2015 758.68K -2.84M -374.73%
2016 1.27M -5.02M -395.23%
2017 228.28K -5.03M -2203.65%
2018 211.84K -5.03M -2378.56%
2019 410.87K -2.72M -662.33%
2020 328.80K -6.36M -1935.59%
2021 0 -13.34M
2022 0 -17.54M
2023 0 -8.37M
2024 0 -6.17M

EDSA Income Statement (2015 – 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
0000328.80K410.87K211.84K228.28K1.27M758.68K
Cost of revenue
0183.47K118.18K118.78K17.60K101.28K445.32K534.45K1.12M840.24K
Gross profit
0-183.47K-118.18K-118.78K311.2K309.58K-233.47K-306.16K143.86K-81.55K
Operating exp.
Research and development
2.88M4.79M13.33M17.94M3.32M1.09M2.08M1.97M1.72M1.02M
Selling and marketing
0-183.47K00000000
Total operating expenses
7.01M9.22M17.59M13.34M6.71M3.14M4.84M4.91M5.05M4.25M
Operating income
-7.01M-9.22M-18.37M-23.68M-6.40M-2.83M-5.07M-5.22M-4.90M-4.33M
Other income (expenses), net
845.49K849.14K822.66K10.33M37.41K55.40K40.10K194.69K-110.52K1.53M
Income before tax
-6.16M-8.37M-17.54M-13.34M-6.36M-2.77M-5.03M-5.02M-5.01M-2.80M
Income tax expense
800800800800800-55.40K8008007.2K36.8K
Net income
-6.17M-8.37M-17.54M-13.34M-6.36M-2.72M-5.03M-5.03M-5.02M-2.84M
Earnings per share
Basic EPS
-1.93-2.93-8.37-7.74-5.18-4.15-10.54-218.72-23.92-15.01
Diluted EPS
-1.93-2.93-8.37-7.73-5.18-4.15-10.54-211.28-23.92-15.01
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source